These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10641280)

  • 1. [Effects of vitamin D metabolites on indicators of protein, phosphorus and calcium metabolism in children with chronic renal failure].
    Denisova SN; Kutafina EK; Sergeeva TV; Savina MI; Kon' IIa; Shilina NM; Chizhevskaia OL; Shilov AV
    Vopr Pitan; 1999; 68(5-6):35-40. PubMed ID: 10641280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of vitamin D metabolites on the markers of protein, calcium and phosphorus turnover in children with chronic renal failure].
    Denisova SN; Kutafina EK; Sergeeva TV; Savina MI; Kon' IIa; Shilina NM; Chizhevskaia OL; Shilov AV
    Vopr Pitan; 1998; (1):14-7. PubMed ID: 9606860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of vitamin D on protein turnover in children with renal osteopathy].
    Denisova SN; Kutafina EK; Kon' IIa; Sergeeva TV; Savina MI
    Vopr Pitan; 1996; (6):31-4. PubMed ID: 9123919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in vitamin D metabolism as they pertain to chronic renal disease.
    Coburn JW; Hartenbower DL; Brickman AS
    Am J Clin Nutr; 1976 Nov; 29(11):1283-99. PubMed ID: 187055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteodystrophy in children with chronic renal insufficiency in dialysis therapy].
    Bartolozzi G; Pela I; Lavoratti GC; Bettucci E; Sirovich A; Pierattelli M; Materassi M
    Pediatr Med Chir; 1982; 4(1-2):65-9. PubMed ID: 6287442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of 1alpha-hydroxycholecalciferol on renal osteodystrophy.
    Castells S; Shai F; Gauthier B; Hashemi SE; Reddy CM; De Luca HF
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):410-9. PubMed ID: 817872
    [No Abstract]   [Full Text] [Related]  

  • 7. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of vitamin D 2 and its metabolites in chronic glomerulonephritis in children].
    Naumova VI; Rusnak FI; Vereskova SA; Kutafina EK; Panchenko EL
    Pediatriia; 1989; (5):19-22. PubMed ID: 2671919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].
    Fournier A; Aparicio M
    Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vitamin D deficiency and its correction in children with terminal stage of chronic kidney failure].
    Tsybysheva AK; Burkov IV; Blazhevich NV; Pereverzeva OG; Spirichev VB
    Vopr Med Khim; 1988; 34(4):112-7. PubMed ID: 3264096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of calcium and phosphorus in hemodialysis.
    Goldsmith RS
    Annu Rev Med; 1976; 27():181-90. PubMed ID: 180871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives.
    Juttmann JR; Buurman CJ; De Kam E; Visser TJ; Birkenhäger JC
    Clin Endocrinol (Oxf); 1981 Mar; 14(3):225-36. PubMed ID: 6973423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
    Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
    Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal osteodystrophy. Calcium and phosphorus metabolism in uremia].
    Ianhez LE
    Rev Hosp Clin Fac Med Sao Paulo; 1974; 29(1):51-6. PubMed ID: 4819004
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic studies of renal osteodystrophy. I. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia and hyperparathyroidism complicating chronic uremia and in the osteomalacia of the adult Fanconi syndrome.
    STANBURY SW; LUMB GA
    Medicine (Baltimore); 1962 Feb; 41():1-34. PubMed ID: 13916186
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal bone disease in peritoneal dialysis.
    Cunningham J
    Perit Dial Int; 1999; 19 Suppl 2():S397-401. PubMed ID: 10406553
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G; Abendroth K; Kokot F; Keil E; Schöne S; Wessel G; Fünfstück R; Sperschneider H
    Z Urol Nephrol; 1985 Mar; 78(3):159-65. PubMed ID: 4002896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior of the vitamin D endocrine system in the development of renal osteodystrophy.
    McCarthy JT; Kumar R
    Semin Nephrol; 1986 Mar; 6(1):21-30. PubMed ID: 3299575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.